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ABSTRACT. The first mixed normal/abnormal NHC ruthenium(II) complexes bearing 
triazole/imidazole based ligands are presented. The ruthenium complexes show differing 
coordination geometries depending on the ligand sphere and the coordination of the triazole. Two 
Ru(II) monocarbene complexes have been obtained, with a 2-imidazolylidene carbene and the 
1,2,3-triazoles acting as neutral nitrogen donors. In addition, a tridentate Ru(II) complex featuring 
a normal 2-imidazolylidene as well as two abnormal 1,2,3-triazolylidene carbene moieties is 
described. Both structural motifs are evaluated in transfer hydrogenation (TH) of acetophenone, 
with the electron rich Ru(II) tri-NHC exhibiting the highest conversion. 
 
INTRODUCTION 
For decades, catalytically active systems have been known to be stabilized by chelating ligands 
in organometallic chemisty.1 Especially polydentate N-heterocyclic carbene (NHC) ligands with 
their strong donor ability show remarkable stability towards various oxidation states in transition 
metal complexes even under harsh conditions.1a-e,1g,2 Bischelating1g,3 and pincer ligands1g,4 are 
amongst the most common ligand motifs of these complexes. Further development of the normal 
NHC systems recently led to a subclass of mesoionic or abnormal N-heterocyclic carbenes, namely 
the 1,2,3-triazolylidene ligands.1c,5 1,2,3-Triazolylidenes combine a significantly higher σ-donor 
strength compared to the widely used classical 2-imidazolylidenes with an almost unlimited 
synthetic access of the ligand precursors through the copper-catalyzed azide−alkyne cycloaddition 
reaction (CuAAC).5d,5e,5g,6 A number of chelating triazolylidene transition metal complexes have 
been described in reports on catalytic as well as spectroscopic and electrochemical 
applications.5g,6a,6b,7 
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Ruthenium N-heterocyclic carbene complexes have been studied extensively for isomerization,8 
hydrogenation,1g,9 metathesis9c,10 and polymerization reactions,11 due to their remarkable ability to 
adapt to a wide range of oxidation states and coordination geometries.9a,12 Reports on chelating 
systems have increased over the years,1g,8a,9a,10a and specific design of ruthenium NHC complexes 
featuring multidentate carbene ligands allows for further insights into the mechanistic aspects of 
catalysis.2c,13 Among various reports on the well-established imidazolylidene or triazolylidene 
carbenes with attached donor sites, the combination of imidazolylidene and triazolylidene carbenes 
with distinctly different properties is an interesting addition to known NHC pincer ligands with 
regard to structural and catalytic versatility.  
Consequently, the first examples of Ru(II) NHC complexes bearing chelating mixed 
normal/abnormal NHC ligands are reported here. The 1,2,3-triazole moieties can act either as 
neutral nitrogen donors or as abnormal/mesoionic carbenes, depending on the substitution pattern 
of the wingtip groups. Single-crystal X-ray diffraction in combination with NMR spectroscopy is 
employed to characterize the complexes both in solid state and in solution. Catalytic studies using 
the resulting monocarbene complexes as well as the tricarbene complex are in accordance with 
mechanistic considerations, and lead the way to a new class of chelating Ru(II) NHC complexes.  
 
RESULTS AND DISCUSSION 
Synthesis of ligand precursors. 
The bis-triazole-functionalized N-heterocyclic carbene ligand precursor L1 is readily accessible 
via conventional copper catalyzed dipolar [2+3] cycloaddition of mesityl azide and the 
corresponding functionalized alkyne (Scheme 1).6e,14 Selective N-functionalization leads to the 
triazolium-imidazolium salt L2 (Scheme 1).  
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Scheme 1. Synthesis of the ligand precursors L1 and L2. 
 
 
Ligand precursor L1 shows different reactivity depending on its counter ion. In situ anion 
exchange from the bromide salt L1·Br (yield 76%) to the OTf- analogue L1·OTf (yield 72%) in 
the reaction mixture is indicated by the characteristic upfield shift of the acidic imidazolium proton 
from δH 11.00 to 9.76 ppm (CDCl3 solution), presumably as a consequence of lesser ion pairing in 
L1·OTf.15 Methylation of the bis-triazole-functionalized precursor L1·OTf at the N3 position with 
MeOTf results in a cleaner reaction than with the bromide analogue and L2 can be obtained in 
good yield (72%). The triazolium protons at δH = 8.69 ppm in L2 show a significant downfield 
shift compared to the corresponding triazole precursor in the 1H spectrum in addition to the 
strongly low field shifted signal of the methyl groups at the N3 position at δH = 4.41 ppm.  
 
Synthesis of the ruthenium complexes. 
Ruthenation of the imidazolium salt L1·Br is accomplished by a one-pot reaction mediated by 
Ag2O at r.t. according to previously reported procedures (Scheme 2).6a,7d Successful complex 
formation of 1a is only observed for the bromide salt ligand, whereas the OTf- analogue does not 
yield any defined products under the applied reaction conditions. The corresponding ruthenium 
complex can be isolated as yellow powder and has been characterized as PF6- salt 1a·PF6 and OTf- 
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salt 1a·OTf in 61 and 58% yield, respectively. Both complexes are stable towards moisture and 
air both in solid state and in solution.  
 
Scheme 2. Ag2O mediated one-pot synthesis of 1a·X in dichloromethane at r.t. 
 
 
Complex 1a is chelated by the ligand derived from L1, thus forming a cationic complex with 
coordination of the imidazolylidene and additional coordination of one triazole via the N3 nitrogen 
as evidenced by NMR spectroscopy and single crystal X-ray diffraction (Figure 1). 
 
 
Figure 1. ORTEP style representation of the cationic complex fragment 1a·PF6 with thermal 
ellipsoids shown at a 50% probability level. Hydrogen atoms and the PF6- counter ion are omitted 
for clarity. The coordinated p-cymene and the mesityl wingtip groups are displayed as wireframe 
for clarity. Selected bond lengths [Å] and angles [°]: Ru1–C13, 2.049(3); Ru1–N3, 2.079(2); Ru1–
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Ccentroid, 1.707; Ru1–Cl1, 2.402(1); C13–Ru1–N3, 83.2(1); C13–Ru1–Cl1, 86.07(8); C13–Ru1–
Ccentroid, 131.39. 
 
Suitable yellow crystals of 1a·PF6 were obtained by slow diffusion of n-pentane into a solution 
of 1a·PF6 in chloroform. X-ray diffraction reveals a classical three-legged piano stool geometry. 
The unit cell contains two crystallographically independent molecules with statistically identical 
structural parameters. Chelation of the triazole moiety produces a six-membered metallacycle with 
a bite angle C–Ru–N of 83.2(1)° and with Ru–C and Ru–N bond distances of 2.049(3) Å and 
2.079(2) Å, respectively. The ruthenium carbene distance is in the range of previously reported 
bond lengths with similar bidentate ligand motifs, the ruthenium nitrogen distance on the other 
hand is slightly shorter than in related ruthenium(II) complexes.16 A palladium(II) mono-NHC 
complex featuring a similar ligand motif, was described recently, however, no chelation was 
reported.17 Interestingly, it was not possible to isolate the related neutral mono-NHC complex with 
two non-coordinated triazole moieties in our case.  
Due to the coordination of one triazole moiety, desymmetrization of the ligand derived from L1 
took place, indicated by splitting of the signals in the 1H NMR spectrum of complex 1a·PF6. Upon 
complexation, the triazole protons become inequivalent, with the non-coordinated triazole proton 
shifted to higher field compared to the coordinated one. The actual chemical shifts are strongly 
influenced by the counter ion and the deuterated solvent. For example, in 1a·PF6 the coordinated 
triazole proton is shifted to δH 7.88 ppm, whereas the non-coordinated one shows a resonance at 
δH 7.33 ppm (CDCl3 solution; for 1a·OTf δH = 7.96 and 7.23 ppm in CDCl3 solution, 
respectively).18 Both bridging methylene groups (δH = 5.17 - 5.81 ppm) become inequivalent with 
the methylene group next to the coordinated triazole exhibiting very broad signals with no defined 
multiplicity. The methylene group next to the non-coordinated triazole on the other hand, is split 
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up into an AB doublet. In addition, the meta protons and the protons of the ortho methyl groups 
of the mesityl substituents become inequivalent upon complexation. The strong influence of the 
solvent is also evident, when 1a·OTf is dissolved in DMSO-d6. The previously broad signals 
become sharp and the methylene bridges split into two AB doublets (δH = 5.10 and 5.44 ppm, 2JHH 
= 15.7 and δH = 5.64 and 5.71 ppm, 2JHH = 16.0, respectively). Even the chemically inequivalent 
para methyl groups of the mesityl substituents as well as the methyl groups of the p-cymene are 
resolved. The desymmetrization pattern is also observed for the 13C spectra for both 1a·PF6 and 
1a·OTf regardless of the employed deuterated solvent. 
A VT-NMR study at elevated temperatures (up to 100 °C) reveals no decoordination of the 
triazole moiety.18 Instead, thermal dissociation of p-cymene and subsequent N-coordination of the 
second 1,2,3-triazole is observed in a DMSO-d6 solution at 120 °C after 2 hours.18 Upon chelation, 
the second triazole becomes almost equivalent with the already coordinated one with a downfield 
shift to δH = 8.78 ppm and the previously different methylene bridges exhibit a singlet signal at δH 
= 5.68 ppm. This splitting pattern is retained after purification and isolation of the resulting 
acetonitrile solvento complex with a singlet signal for the two coordinated triazole protons at δH = 
8.07 ppm in a CD3CN solution.18 Due to the high symmetry in the 1H NMR spectrum and the fact 
that the methylene bridges are chemically equivalent, a meridional structural motif of the ligand 
derived from L1 is proposed. Complementary ESI-MS studies suggest the bonding of a chloride 
to the ruthenium center, which is in agreement with a N,C,N-tridentate coordinating ligand, an 
equatorially bound chloride and two acetonitrile ligands in axial positions.18  
 
In order to evaluate the versatility of the ligand precursor L1, the synthesis of the corresponding 
tridentate cationic ruthenium(II) complex was attempted. Complex 1b was prepared from complex 
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1a·OTf by AgOTf mediated abstraction of the chloride ligand in the presence of the coordinating 
solvent MeCN in 33% yield (Scheme 3).  
 
Scheme 3. Synthesis of the tridentate complex 1b. 
 
 
Suitable single crystals of 1b were obtained by slow diffusion of n-pentane into a solution of 1b 
in chloroform/dichloromethane. The molecular structure of 1b was established by single-crystal 
X-ray diffraction and confirms a three-legged piano stool geometry with the N,C,N-tridentate 
coordinated ligand in a facial bonding mode. Chelation gave two six-membered metallacycles with 
a Ru–C distance of 2.053(4) Å and Ru–N distances that are equal within standard deviations (Ru–




Figure 2. ORTEP style representation of the cationic complex fragment 1b with thermal ellipsoids 
shown at a 50% probability level. Hydrogen atoms and OTf- counter ions are omitted for clarity. 
The mesityl wingtip groups and the coordinated p-cymene are displayed as wireframe for clarity. 
Selected bond lengths [Å] and angles [°]: Ru1–C15, 2.053(4); Ru1–N3, 2.090(3); Ru1–N6, 
2.081(4); Ru1–Ccentroid, 1.713; C15–Ru1–N3, 81.7(1); C15–Ru1–N6, 81.2(1); C15–Ru1–Ccentroid, 
133.00. 
 
Both the ruthenium carbon distance as well as the ruthenium nitrogen distances are similar to 
the distances found in complex 1a·PF6 and are therefore within the range of previously reported 
bond lengths with similar multidentate ligand motifs.16a,16b,16d In the 1H NMR spectrum the change 
from bidentate coordination to tridentate coordination is obvious due to symmetry-relation of the 
two triazole units which appear as a single set of signals. Upon coordination, the previously non-
coordinated triazole proton becomes equivalent with the already coordinated triazole and is low 
field shifted to 8.10 ppm in CD2Cl2. The bridging methylene groups split into a single AB doublet 
(δH = 5.49 and 5.88 ppm, 2JHH = 16.2 Hz). Likewise, the meta protons become chemically 
equivalent as well as the protons of the ortho methyl groups of the mesityl substituents. A VT-
NMR study reveals splitting of the broad mesityl substituent signals at lower temperatures with 
sharp signals at -90 °C.18 No desymmetrization of the methylene linker between the 
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imidazolylidene and the triazole unit was observed at this temperature, and therefore the process 
leading to decoalescence might be attributed to a hindered rotation about the Ntrz–CMes bond rather 
than a N-decoordination involving a species related to 1a. 
 
Ruthenation of the mixed imidazolium/triazolium salt L2 is accomplished by a microwave 
mediated one-pot reaction according to a previously reported procedure (Scheme 4).13a  
 




Monomeric Ru(II) complex 2 can be isolated as yellow powder and is stable towards air and 
moisture. The cationic complex is highly soluble in acetonitrile, but poorly soluble in non-polar 
solvents like Et2O and n-pentane. Successful complexation is indicated by characteristic NMR data 




Figure 3. ORTEP style representation of the cationic complex fragment 2 with thermal ellipsoids 
shown at 50% probability. Hydrogen atoms and OTf- counter ions are omitted for clarity. Selected 
bond lengths [Å] and angles [°]: Ru1–C11, 2.096(4); Ru1–C16, 2.015(5); Ru1–C19, 2.091(4); 
Ru1–N9, 2.102(4); Ru1–N10, 2.019(4); Ru1–N11, 2.015(4); C11–Ru1–C16, 85.3(2); C11–Ru1–
C19, 170.1(2); C11–Ru1–N9, 95.5(2); C11–Ru1–N10, 92.5(2); C16–Ru1–N9, 179.1(2). 
 
Suitable single crystals of 2 were obtained by slow diffusion of Et2O into a solution of 1b in 
MeCN. The complex exhibits a distorted octahedral geometry, with the mixed normal/abnormal 
NHC ligand being coordinated in a meridional fashion. In addition, p-cymene is substituted by 
three MeCN ligands, facilitating the observed meridional bonding mode. The Ru–C bond distance 
of the normal carbene of 2.015(5) Å is in the range of previously reported bond lengths featuring 
multidentate NHC ligands.3a,13a,13e,19 The ruthenium carbene bond distances of the abnormal 
carbenes are identical within standard deviations (2.091(4) and 2.096(4) Å) and are slightly longer 
than previously reported bond lengths for abnormal triazolylidene ruthenium(II) 
complexes.5d,6a,7a,7d,20 It is worth pointing out that the ligand parameters of complex 1b and 2 are 
very similar. 
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Meridional coordination of the ligand is also supported by NMR spectroscopy with a single 
signal for the two terminal methyl groups at the N3 position of the triazolylidene at δH = 4.20 ppm 
and two additional singlets for the methyl groups of the two mesityl substituents at δH = 2.33 and 
1.88 ppm in the 1H NMR spectrum. The methylene bridges in 2 are chemically equivalent and 
exhibit a singlet signal at δH 5.33 ppm, which also confirms the symmetrical meridional 
conformation especially when compared to the AB slitting pattern of the facial coordinating ligand 
in complex 1b. In the 1H NMR spectrum the coordinated acetonitrile ligands correspond to two 
signals at δH 1.96 and 2.03 ppm with integral three and six, respectively. The acetonitrile at δH 
1.96 ppm corresponds to free acetonitrile, which is due to an exchange on NMR time scale. In the 
13C NMR spectrum only one set of signals is observed for the acetonitrile ligands, with the second 
set lying under the signals of the NMR solvent CD3CN. The 13C NMR spectrum also shows two 
characteristic independent carbene carbon shifts at δC = 172.6 and 185.3 ppm for the triazolylidene 
and imidazolylidene carbons, respectively. 
To the best of our knowledge, complex 2 constitutes the first example of a mixed 
normal/abnormal tri-NHC complex of ruthenium reported to date and allows first insights into 
steric and electronic properties of this ligand motif. Especially the easy synthesis of the ligand 
precursor via dipolar [2+3] cycloaddition of mesityl azide and the corresponding functionalized 
alkyne will enable further tailoring of the steric properties of the wing tip groups.  
 
Transfer Hydrogenation Catalysis. Complexes 1a (for comparison reasons 1a·OTf was used 
for all catalytic experiments), 1b and 2 were investigated as catalyst precursors for ketone 
reduction via transfer hydrogenation. Standard protocols were applied consisting of basic 2-
propanol as formal dihydrogen donor and acetophenone as model substrate (Scheme 5).9b,13a 1a 
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(0.5 mol%), 1b (0.5 mol%) and 2 (0.5 mol%) display catalytic activity in the presence of NaOiPr 
(5 mol%) in 2-propanol at reflux conditions. Acetophenone is reduced to the corresponding alcohol 
1-phenyl ethanol with 85%, 84% and 98% conversion within 180, 120 and 80 min, respectively, 
achieving turnover frequencies (TOFs) up to 1100 h-1 (summarized in Figure 4).18 
 





Figure 4. Catalytic performance of 1a, 1b and 2 in the transfer hydrogenation of acetophenone. 
Reaction conditions: acetophenone (1 mmol), NaOiPr (0.05 mmol, 5 mol%), iPrOH 10 mL, 
catalyst loading (0.5 mol%), 82 °C. Conversions determined via GC analysis as average over two 
catalytic runs using anisole as internal standard. 
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Although the catalytic activity does not reach the highest reported reactivity for Ru TH pre-
catalysts,9b,9e,13a,16c,21 complexes 1a and 1b show comparable or significantly higher conversions 
than N-donor functionalized related compounds.16a,16e,22 It is, however, noteworthy, that 1b, with 
both triazole moieties coordinated to the ruthenium center, exhibits the highest (initial) turnover 
frequency (TOF2min) of 1100 h-1 (19% conversion), compared to 1a with a TOF4min of 280 h-1 (6% 
conversion) and 2 with a TOF2min of 580 h-1 (10% conversion). After reaching a conversion of 60% 
1b slows down significantly. The mixed normal/abnormal NHC complex 2 turned out to be a more 
robust TH precursor compared to the monocarbene complexes 1a and 1b, possibly due to a 
stronger chelating effect and a higher electron density at the metal center. Compound 2 establishes 
this novel structural motif as a viable alternative to existing Ru TH catalysts. The catalyst can be 





The first Ru(II) mixed normal/abnormal NHC complexes derived from triazolium/imidazolium 
salts are presented. Two Ru(II) monocarbene complexes were obtained, with a 2-imidazolylidene 
skeleton and two 1,2,3-triazoles acting as neutral nitrogen donors. In addition, the tridentate Ru(II) 
complex featuring normal as well as abnormal carbene moieties is described. This unusual 
combination of one 2-imidazolylidene and two 1,2,3-triazolylidenes connected by methylene 
bridges constitutes the first example of a transition metal complex featuring a chelating mixed tri-
NHC ligand. This combination of normal and abnormal NHC moieties potentially influences the 
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activity on the ruthenium complexes as catalyst precursors in transfer hydrogenation. Especially 
coordination of 1,2,3-triazole as neutral nitrogen donor vs. coordination as mesoionic 
triazolylidene ligand highlight the various possibilities of mixed NHC ligands for catalytic 
applications and provide a platform for further examination of this motif. Consequently, specific 
tailoring of the coordination geometry of ruthenium tri-NHC complexes holds great potential for 
the development of efficient homogeneous catalyst systems and will be further investigated. As so 
far no mixed NHC transition metal complexes have been reported, these results should be seen as 
an incentive to exploit the stabilizing properties of such tridentate ligand structures in the future. 
 
EXPERIMENTAL SECTION 
General Comments. All reactions were performed under an atmosphere of dry argon in oven-
dried glassware using standard Schlenk techniques. All reagents were purchased from commercial 
sources and used without further purification. Mesityl azide23 and [Ru(p-cymene)Cl2]224 were 
synthesized according to literature procedures. 
Microwave reactions were carried out using a CEM Discover microwave synthesizer, operating 
at 100 W irradiation power. Chromatographic separations were performed using silica gel (40 - 63 
µm). NMR spectra were recorded with a Bruker Avance DPX 400, a Bruker Avance III 400 and a 
Bruker Avance I 500 spectrometer at a temperature of 298 K. The spectra were referenced to the 
residual solvent signals in parts per million (ppm). Abbreviations for NMR multiplicities are: 
singlet (s), doublet (d), triplet (t), septet (sept), multiplet (m). Coupling constants J are given in 
Hz. All 13C NMR spectra are 1H decoupled. Electrospray ionization spectra (ESI) were obtained 
on a Thermo Scientific LCQ/Fleet spectrometer by Thermo Fisher Scentific. GC analysis was done 
with an HP 6890 GC system using an Agilent DB-225ms column (24.8 m x 250 μm x 0.25 μm). 
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Elemental analyses were performed in the microanalytical laboratories of Technische Universität 
München and University College Dublin. 
Synthesis of 1,3-dipropargylimidazolium bromide.25 A solution of imidazole (2.04 g 30.0 
mmol) in dry tetrahydrofuran (40 mL) was slowly added to a solution of sodium hydride (1.31 g, 
732.7 mmol) in dry tetrahydrofuran (40 mL). After stirring for 15 min at room temperature, a 
solution of propargyl bromide (80% in toluene, 8.32 mL, 75.0 mmol) in dry THF (20 mL) was 
added quickly at 0 °C. The reaction mixture was allowed to warm to r.t. and stirred overnight, 
before stirring for 2 h at 60 °C. The solution was cooled down to 0 °C and precipitated with Et2O 
(100 mL). The brown residue was dissolved in methanol and precipitated with Et2O (100 mL). 
Subsequently, the residue was suspended in acetonitrile and filtrated. The filtrate was concentrated 
under reduced pressure and washed with cold acetone to yield 1,3-dipropargylimidazolium 
bromide (2.59 g, 38%) as a colorless powder. 
1H NMR (400.13 MHz, DMSO-d6): δ = 9.50 (s, 1H, Him), 7.91 (d, ³ J = 1.6 Hz, 2H, Him), 5.30 
(d, ³J = 2.5 Hz, 4H, CH2), 3.87 (t, 4J = 2.6 Hz, 2H, CH). 
13C NMR (100.62 MHz, DMSO-d6): δ = 136.2 (Cim), 122.7 (Cim), 79.1 (Cq), 76.0 (CH), 38.8 
(CH2). 
Anal. Calcd for C9H9BrN2 (225.09): C, 48.03; H, 4.03; N, 12.45. Found: C, 47.69; H, 3.85; N, 
12.16. 
Synthesis of L1·Br. Mesityl azide (161 mg, 1.00 mmol), and 1,3-dipropargylimidazolium 
bromide (113 mg, 0.50 mmol) were suspended in a mixture of water (2 mL) and tert-BuOH (2 
mL). CuSO4 (11.2 mg, 0.07 mmol), and copper powder (1.59 mg, 0.03 mmol) were added and the 
mixture was stirred for 2 h at 100 °C under microwave irradiation. After cooling, the reaction 
mixture was extracted with CH2Cl2 (3 × 20 mL). The combined organic phases were washed with 
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aqueous ammonia (3 × 15 mL) and brine (3 × 15 mL) and dried over MgSO4. The solvent was 
removed under reduced pressure. The resulting residue was dissolved in CH2Cl2 and precipitated 
with pentane (50 mL) to give the pure triazole/imidazole ligand L1·Br as a pale brown powder 
(208 mg, 76%). 
1H NMR (400.13 MHz, CDCl3): δ = 11.00 (s, 1H, Him), 8.27 (s, 2H, Htrz), 7.68 (s, 2H, Him), 6.94 
(s, 4H, CHmes), 5.86 (s, 4H, CH2), 2.33 (s, 6H, CH3), 1.88 (s, 12H, CH3). 
13C NMR (100.62 MHz, CDCl3): δ = 140.5 (Cq,mes), 140.0 (Cq,trz), 137.9 (Cim), 134.9 (Cq,mes), 133.0 
(Cq,mes), 129.3 (CHmes), 127.0 (CHtrz), 122.3 (CHim), 44.5 (CH2), 21.2 (CH3para), 17.5 (CH3ortho). 
MS-ESI (m/z): [L1·Br-Br]+ 467.23. 
Synthesis of L1·OTf. In order to obtain L1·OTf instead of the bromide salt, KOTf (235mg, 1.25 
mmol) was added to the reaction mixture prior to extraction with CH2Cl2. The pure 
triazole/imidazole ligand L1·OTf is obtained as an off white powder (221 mg, 72%). 
1H NMR (400.13 MHz, CDCl3): δ = 9.76 (s, 1H, Him), 8.10 (s, 2H, Htrz), 7.65 (s, 2H, Him), 6.95 
(s, 4H, CHmes), 5.70 (s, 4H, CH2), 2.33 (s, 6H, CH3), 1.88 (s, 12H, CH3). 
13C NMR (100.62 MHz, CDCl3): δ = 140.5 (Cq,mes), 149.7(Cq,trz), 136.9 (Cim), 134.9 (Cq,mes), 133.0 
(Cq,mes), 129.3 (CHmes), 126.9 (CHtrz), 122.6 (CHim), 44.6 (CH2), 21.2 (CH3para), 17.4 (CH3ortho). 
MS-ESI (m/z): [L1·OTf-OTf]+ 467.28. 
Anal. Calcd for C28H31F3N8O3S (616.66): C, 54.54; H, 5.07; N, 18.17; S, 5.20. Found: C, 54.42; 
H, 5.13; N, 18.09; S, 4.99. 
Synthesis of L2. To a solution of L1·OTf (400 mg, 0.65 mmol) in CH2Cl2 (20 mL) was added 
MeOTf (255 mg, 1.56 mmol) and the mixture was stirred in a closed Schlenk tube overnight at 
RT. The white suspension was concentrated to half its original volume, and the product was 
precipitated with diethyl ether. The raw brown solid was purified via repeated precipitation from 
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MeCN/Et2O. Washing with n-pentane and removal of the residual solvent under reduced pressure 
yielded L2 (442 mg, 72 %) as a colorless solid. 
1H NMR (400.13 MHz, CD3CN): δ = 9.31 (s, 1H, Him), 8.69 (s, 2H, Htrz), 7.79 (d, J = 1.6 Hz, 
2H, Him), 7.16 (s, 4H, CHmes), 5.88 (s, 4H, CH2), 4.41 (s, 6H, NCH3), 2.37 (s, 6H, CH3), 2.04 (s, 
12H, CH3). 
13C NMR (100.62 MHz, CD3CN): δ = 144.0 (Cq,mes), 139.5 (Cim), 138.9 (Cq,trz), 135.7 (Cq,mes), 
133.8 (CHtrz), 132.1 (Cq,mes), 130.7 (CHmes), 125.0 (Cim), 42.8 (CH2), 40.2 (NCH3), 21.2 (CH3para), 
17.3 (CH3ortho).  
MS-ESI (m/z): [L2-OTf]+ 795.10; [L2-2OTf]2+ 323.07; [L2-3OTf]3+ 165.80. 
Anal. Calcd for C32H37F9N8O9S3 (944.86): C, 40.68; H, 3.95; N, 11.86; S, 10.18. Found: C, 40.61; 
H, 4.01; N, 11.79; S, 10.15. 
Synthesis of complex 1a. A mixture of L1·Br (75.1 mg, 0.14 mmol), Ag2O (14.6 mg, 0.06 
mmol) and [Ru(p-cymene)Cl2]2 (38.6 mg, 0.06 mmol) in CH2Cl2 (10 mL) was stirred in the dark 
at room temperature for 72 h. The suspension was filtered through celite and the solvent was 
removed under reduced pressure. 
a) isolated as 1a·PF6. The pale brown residue was dissolved in CH2Cl2 (5 mL), NH4PF6 (30.8 
mg, 0.19 mmol) was added and the mixture was stirred at room temperature for 5 h and 
subsequently filtered through celite. Precipitation with n-pentane and drying under reduced 
pressure yields 1a·PF6 as yellow solid. Analytically pure yellow crystals of 1a·PF6 were 
obtained by recrystallization from CHCl3/n-pentane (68 mg, 61%). 
1H NMR (400.13 MHz, CDCl3): δ = 7.91 (s, 1H, Him), 7.88 (s, 1H, Htrz,coord), 7.33 (s, H, Htrz), 
7.22 (s, 1H, Him), 6.99 (s, 2H, CHmes), 6.98 (s, 2H, CHmes), 5.92 (d, J = 5.8 Hz, 2H, Hcym), 5.81 (d, 
J = 11.5 Hz, 1H, CH2), 5.64 (d, J = 5.4 Hz, 2H, Hcym), 5.59 (m, 1H, CH2), 5.51 (d, J = 5.8 Hz, 1H, 
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CH2), 5.17 (d, J = 16.0 Hz, 1H, CH2), 2.87 (sept, 1H, CHMe2), 2.35 (s, 6H, CmesCH3), 2.21 (s, 3H, 
CcymCH3), 1.99 (s, 6H, CmesCH3), 1.95 (s, 6H, CmesCH3), 1.23 (d, J = 6.8 Hz, 6H, CHcymCH3). 
13C NMR (100.62 MHz, CDCl3): δ = 173.8, 142.1, 141.1, 140.4, 135.1, 135.0, 133.3, 132.8, 
129.5, 129.3, 126.3, 125.8, 124.3, 121.9, 111.5, 102.3, 87.9, 87.5, 87.4, 83.8, 46.0, 44.3, 31.5, 24.0, 
21.3, 21.3, 21.1, 19.0, 17.6, 17.5. 
31P NMR (161.97 MHz, CDCl3): δ = -144.4 (sept, PF6). 
MS-ESI (m/z): [1a·PF6-PF6]+ 737.19. 
Anal. Calcd for C37H44ClF6N8PRu x 0.67 CHCl3 (961.88): C, 47.03; H, 4.68; N, 11.65. Found: 
C, 47.33; H, 4.67; N, 11.80. 
b) isolated as 1a·OTf. The pale brown residue is dissolved in CH2Cl2 (5 mL), KOTf (35.6 mg, 
0.19 mmol) was added and the mixture was stirred at room temperature overnight and 
subsequently filtered through celite. Precipitation with n-pentane and drying under reduced 
pressure yielded 1a·OTf (64.8 mg, 58%) as light brown solid.  
1H NMR (400.13 MHz, DMSO-d6): δ = 8.71 (s, 1H, Htrz,coord), 8.48 (s, 1H, Htrz), 7.73 (d, J = 1.8 
Hz, 1H, Him), 7.58 (d, J = 1.8 Hz, 1H, Him), 7.16 (s, 2H, CHmes), 7.13 (s, 2H, CHmes), 6.01(m, 2H, 
Hcym), 5.85 (m, 2H, Hcym), 5.71 (d, J = 16.0 Hz, 1H, CH2), 5.64 (d, J = 6.0 Hz, 1H, CH2), 5.44 (d, J 
= 15.4 Hz, 1H, CH2), 5.10 (d, J = 15.9 Hz, 1H, CH2), 2.77 (sept, 1H, CHMe2), 2.35 (s, 3H, 
CmesCH3), 2.34 (s, 3H, CmesCH3), 2.06 (s, 3H, CcymCH3), 1.95 (s, 6H, CmesCH3), 1.92 (s, 6H, 
CmesCH3), 1.15 (d, J = 6.9 Hz, 3H, CHcymCH3), 1.10 (d, J = 6.8 Hz, 3H, CHcymCH3). 
13C NMR (100.62 MHz, CDCl3): δ = 173.5, 142.2, 141.1, 140.5, 135.0, 134.9, 132.8, 129.5, 
129.3, 126.2, 124.5, 121.8, 111.1, 102.4, 88.1, 87.6, 87.4, 83.8, 45.8, 44.6, 31.5, 23.9, 21.3, 21.3, 
21.2, 19.1, 17.7, 17.4. 
MS-ESI (m/z): [1a·OTf-OTf]+ 737.18. 
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Anal. Calcd for C38H44ClF3N8O3RuS (886.40): C, 51.49; H, 5.00; N, 12.64; S, 3.62. Found: C, 
51.25; H, 5.23; N, 12.33; S, 3.55. 
Synthesis of complex 1b. A mixture of 1a·OTf (150 mg, 0.17 mmol) and AgOTf (52.2 mg, 
0.20 mmol) in MeCN (3 mL) was stirred in the dark at 50 °C overnight and then filtered through 
celite. The mixture was dissolved in CH2Cl2 and precipitated with Et2O. Precipitation from MeCN 
with Et2O and drying under reduced pressure yielded 1b as light yellow solid. Analytically pure 
yellow crystals of 1b were obtained by recrystallization from CHCl3/CH2Cl2/n-pentane (55 mg, 
33%). 
1H NMR (400.13 MHz, CD2Cl2): δ = 8.10 (s, 2H, Htrz), 7.54 (s, 2H, Him), 7.00 (s, 4H, CHmes), 
5.97 (d, J = 6.3 Hz, 2H, Hcym), 5.88 (d, J = 16.2 Hz, 2H, CH2), 5.88 (d, J = 6.4 Hz, 2H, Hcym), 5.49 
(d, J = 16.2 Hz, 2H, CH2), 2.79 (sept, J = 7.4 Hz, 1H, CHMe2), 2.34 (s, 6H, CmesCH3), 2.31 (s, 3H, 
CcymCH3), 1.84 (s, 12H, CmesCH3), 1.28 (d, J = 6.9 Hz, 6H, CHcymCH3). 
13C NMR (100.62 MHz, CD3CN): δ = 176.6 (Cim), 144.8 (Ctrz), 142.6 (Cq,mes), 135.7 (Cq,mes), 
133.3 (Cq,mes), 130.3 (CHmes), 127.6 (CHtrz), 125.0 (CHim), 91.4 (CHcym), 87.0 (CHcym), 45.7 (CH2), 
32.5 (CHcymMe2), 22.7 (CHcym(CH3)2), 21.1 (CH3,mes,para), 19.4 (CH3,cym), 17.5 (CH3,mes,ortho). 
19F NMR (376.46 MHz, CD2Cl2): δ = -78.9 (s, OTf). 
MS-ESI (m/z): [1b-OTf]+ 850.89, [1b-2OTf]2+ 351.21. 
Anal. Calcd for C39H44F6N8O6RuS2 x 0.5 CH2Cl2 (1042.47): C, 45.51; H, 4.35; N, 10.75; S, 6.15. 
Found: C, 45.53; H, 4.41; N, 10.93; S, 6.58. 
Synthesis of complex 2. 5 mL of acetonitrile was added to a mixture of L2 (150 mg, 0.159 
mmol), Ag2O (54.1 mg, 0.233 mmol) and [RuCl2(p-cymene)]2 (47.6 mg, 0.078 mmol). The orange 
mixture was stirred for 1 h at 100 °C under microwave irradiation. After cooling, the mixture was 
filtered over celite and the volatiles were removed under reduced pressure. The residue was 
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purified by column chromatography (SiO2; CH2Cl2 : MeCN = 1:1) to give 2 as pale yellow powder. 
Clear yellow crystals were obtained after crystallization from MeCN/Et2O by slow diffusion (63 
mg, 40%). 
1H NMR (400.13 MHz, CD3CN): δ = 7.36 (s, 2H, Him), 7.05 (s, 4H, CHmes), 5.33 (s, 4H, CH2), 
4.20 (s, 6H, NCH3), 2.33 (s, 6H, CmesCH3), 2.03 (s, 6H, CH3CN), 1.96 (d s, 3H, CH3CN), 1.88 (s, 
12H, CmesCH3). 
13C NMR (100.62 MHz, CD3CN): δ = 185.3 (Cim), 172.6 (Ctrz), 141.3 (Ctrz), 141.0 (Cq,mes), 137.3 
(Cq,mes), 136.3 (Cq,mes), 129.6 (CHmes), 124.9 (CH3CN), 123.1 (CHim), 45.2 (CH2), 37.3 (NCH3), 21.1 
(CH3,mes,para), 17.4 (CH3,mes,ortho), 4.3 (CH3CN). 
19F NMR (376.46 MHz, CD3CN): δ = -79.4 (s, OTf). 
MS-ESI (m/z): [2-OTf]+ 867.35, [2-OTf-MeCN]+ 826.35, [2-OTf-2MeCN]+ 785.56, [2-OTf-
3MeCN]+ 745.08, [2-2OTf-MeCN]2+ 338.58, [2-2OTf-2MeCN]2+ 318.30, [2-2OTf-3MeCN]2+ 
297.22. 
Anal. Calcd for C37H43F6N11O6RuS2 x MeCN (1058.06): C, 44.27; H, 4.38; N, 15.89. Found: C, 
44.20; H, 4.39; N, 15.91. 
Transfer Hydrogenation Catalysis. Catalytic transfer hydrogenation reactions were carried out 
under an argon atmosphere in Schlenk tubes. In a typical experiment, the reactor was charged with 
2-propanol (9.8 ml), the ketone (1 mmol), anisole (50.5 μL) and the respective amount of catalyst 
(0.5 mol%).9b,13a The mixture was heated to reflux for 1 min and a 0.1 M solution of NaOiPr in 2-
propanol (200 μL, 0.05 mmol, 5 mol%) was added to the stirred mixture. 0.5 mL aliquots of the 
reaction mixture were taken at the required reaction times and immediately cooled down to 0 °C, 
filtered over a short pad of silica and quenched with 1 mL of diethyl ether in a GC vial. 
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Subsequently, the mixture was analyzed by gas chromatography. The conversion of the ketone and 
the yield of alcohol were calculated according to the internal standard. 
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